The increased sensitivity to SG3199 of cells defective in homologous recombination repair and DNA repair protein ERCC1, as shown previously for SG200023, suggest a possible widening of therapeutic index in patients with tumours harbouring these defects, and indicates potential biomarkers of response. Here, ERCC1 is linked to neoplasm.